MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
$31,660K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net income
Increase/(decrease) in accrued a...
Stock-based compensation expense
Others
Negative Cash Flow Breakdown
Non-cash effect of change in est...
Cash related to stock repurchase...
Members' distributions
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Net income
96,317
-100,986
96,799
16,144
Depreciation and amortization
5,317
-9,851
5,003
5,248
Gain on warrant liability
-
-
-
0
Loss on warrant liability
-
-
0
-
Impairment of assets
-
-
0
0
Impairment of goodwill
-
-
0
0
Derecognition of goodwill
-
-
0
0
Stock-based compensation expense
2,884
-123,521
13,217
78,747
Changes to deferred taxes
2,707
-23,874
27,807
-2,365
Debt accretion expense
11
-723
252
251
Non-cash effect of change in estimate
52,319
-
-
-
(increase)/decrease in accounts receivable-Nonrelated Party
12,115
-134,840
38,192
54,135
(increase)/decrease in accounts receivable-Related Party
-1,314
-3,390
1,616
1,479
(increase)/decrease in inventories
-472
1,505
883
-843
(increase)/decrease in income tax receivable
-
-
12,097
-
(increase)/decrease in prepaid expenses and other current assets
2,096
-12,594
-2,264
7,262
(increase)/decrease in operating right-of-use assets
404
-117
397
-285
Increase/(decrease) in accounts payable-Nonrelated Party
-4,356
-36,348
17,303
9,112
Increase/(decrease) in accounts payable-Related Party
1,759
-2,460
2,107
-165
Increase/(decrease) in operating lease liabilities
-348
-216
-358
439
Increase/(decrease) in accrued arbitration expenses
-7,639
9,481
4,472
-16,982
Increase/(decrease) in accrued income tax expense
-11,588
41,260
-8,364
-37,767
Increase/(decrease) in accrued expenses and other current liabilities
-1,802
2,683
347
2,949
Net cash provided by operating activities
34,200
-102,218
99,514
27,257
Acquisitions of property and equipment
2,540
84
302
751
Proceeds from restricted short-term investment
-2,941
-
0
2,941
Cash related to sale of business
-
-
0
0
Cash related to asset acquisition
-1,994
-
0
1,994
Net cash provided by (used in) investing activities
-2,540
-1,031
-302
196
Proceeds from lines of credit
0
-5,043
437
742
Proceeds from notes payable
0
-273
15
258
Repayments of lines of credit
48
-2,699
2,992
9
Repayments of notes payable
1,399
-6,765
2,622
5,697
Repayments of finance leases
1,764
-2,451
1,411
1,226
Proceeds from common stock issuance, net issuance costs
-
-
0
0
Proceeds from exercise of warrants
75
-
0
-
Cash related to stock repurchases and retirements
18,958
31,730
-
-
Members' contributions
166
923
74
242
Members' distributions
13,263
-26,817
23,398
11,412
Net cash used in financing activities
-35,191
2,609
-29,897
-15,449
Net change in cash, cash equivalents, and restricted cash
-3,531
-100,640
69,315
12,004
Cash and cash equivalents - end of period
185,574
-
-
-
Restricted cash - beginning of period
297
-
-
-
Cash and cash equivalents and restricted cash - beginning of period
185,871
-
-
-
Cash and cash equivalents - beginning of the period
205,208
-
-
-
Cash and cash equivalents at beginning of period
-
-
84,729
84,729
Restricted cash - end of period
1,900
-
-
-
Cash and cash equivalents at end of period
-
-
166,048
96,733
Cash and cash equivalents and restricted cash - end of period
207,108
-
-
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$96,317K
(496.61%↑ Y/Y)
Increase/(decrease) in accrued
arbitration expenses
-$7,639K
(55.02%↑ Y/Y)
Depreciation and
amortization
$5,317K
(1.31%↑ Y/Y)
Stock-based compensation
expense
$2,884K
(-96.34%↓ Y/Y)
Changes to deferred
taxes
$2,707K
(214.46%↑ Y/Y)
Increase/(decrease) in accounts
payable-Related Party
$1,759K
(1166.06%↑ Y/Y)
(increase)/decrease in accounts
receivable-Related Party
-$1,314K
(-188.84%↓ Y/Y)
(increase)/decrease in inventories
-$472K
(44.01%↑ Y/Y)
(increase)/decrease in operating
right-of-use assets
$404K
(241.75%↑ Y/Y)
Debt accretion
expense
$11K
(-95.62%↓ Y/Y)
Net cash provided by
operating activities
$34,200K
(25.47%↑ Y/Y)
Canceled cashflow
$84,624K
Net change in cash,
cash equivalents,...
-$3,531K
(-129.42%↓ Y/Y)
Canceled cashflow
$34,200K
Members' contributions
$166K
(-31.40%↓ Y/Y)
Proceeds from exercise of
warrants
$75K
Cash related to asset
acquisition
-$1,994K
(-200.00%↓ Y/Y)
something is missing
$947K
Non-cash effect of change
in estimate
$52,319K
(increase)/decrease in accounts
receivable-Nonrelated Party
$12,115K
(-77.62%↓ Y/Y)
Increase/(decrease) in accrued
income tax expense
-$11,588K
(69.32%↑ Y/Y)
Increase/(decrease) in accounts
payable-Nonrelated Party
-$4,356K
(-147.81%↓ Y/Y)
(increase)/decrease in prepaid
expenses and other...
$2,096K
(-71.14%↓ Y/Y)
Increase/(decrease) in accrued
expenses and other...
-$1,802K
(-161.11%↓ Y/Y)
Increase/(decrease) in operating
lease liabilities
-$348K
(-179.27%↓ Y/Y)
Net cash used in
financing activities
-$35,191K
(-127.79%↓ Y/Y)
Canceled cashflow
$241K
Net cash provided by
(used in) investing...
-$2,540K
(-1395.92%↓ Y/Y)
Canceled cashflow
$2,941K
Cash related to stock
repurchases and retirements
$18,958K
Members' distributions
$13,263K
(16.22%↑ Y/Y)
Repayments of finance
leases
$1,764K
(43.88%↑ Y/Y)
Repayments of notes payable
$1,399K
(-75.44%↓ Y/Y)
Repayments of lines of
credit
$48K
(433.33%↑ Y/Y)
Proceeds from restricted
short-term investment
-$2,941K
(-200.00%↓ Y/Y)
Acquisitions of property and
equipment
$2,540K
(238.22%↑ Y/Y)
Buy us a coffee
Nutex Health Inc. (NUTX)
Nutex Health Inc. (NUTX)